Trial Profile
Evaluation of selective COX-2 inhibitor for the protection of intestinal mucosal damage in comparison to NSAID in patients with rheumatoid arthritis (Investigation by capsule endoscopy and measurement of biomarkers for rheumatoid arthritis).
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 05 Dec 2015
Price :
$35
*
At a glance
- Drugs Celecoxib (Primary)
- Indications Musculoskeletal pain; Rheumatoid arthritis
- Focus Adverse reactions; Biomarker
- 28 Sep 2013 Status changed from active, no longer recruiting to completed as reported by University Hospital Medical Information Network - Japan record.
- 07 Jan 2013 Status changed from recruiting to active, no longer recruiting as reported by University Hospital Medical Information Network - Japan record.
- 03 Oct 2009 New trial record